tradingkey.logo

Haleon PLC

HLN

9.430USD

-0.210-2.18%
Fechamento 07/31, 16:00ETCotações atrasadas em 15 min
85.37BValor de mercado
59.20P/L TTM

Haleon PLC

9.430

-0.210-2.18%
Mais detalhes de Haleon PLC Empresa
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Informações da empresa
Código da empresaHLN
Nome da EmpresaHaleon PLC
Data de listagemJul 18, 2022
Fundado em2021
CEOMr. Brian Mcnamara
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 18
EndereçoBuilding 5, First Floor
CidadeWEYBRIDGE
Bolsa de valoresLondon Stock Exchange
PaísUnited Kingdom
Código postalKT13 0NY
Telefone441932822000
Sitehttps://www.haleon.com/
Código da empresaHLN
Data de listagemJul 18, 2022
Fundado em2021
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
444.67K
+0.83%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ed Petter
Mr. Ed Petter
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
444.67K
+0.83%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Detalhamento da receita
Moeda: GBPAtualizado em: dom, 6 de jul
Moeda: GBPAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaGBP
Nome
Receita
Proporção
Oral health
880.00M
30.84%
Pain relief
661.00M
23.17%
Respiratory health
465.00M
16.30%
Digestive health and other
431.00M
15.11%
Vitamins, minerals and supplements
416.00M
14.58%
Por RegiãoGBP
Nome
Receita
Proporção
EMEA and LatAm
1.19B
41.64%
Northern America
980.00M
34.35%
APAC
685.00M
24.01%
Por Empresa
Por Região
Por EmpresaGBP
Nome
Receita
Proporção
Oral health
880.00M
30.84%
Pain relief
661.00M
23.17%
Respiratory health
465.00M
16.30%
Digestive health and other
431.00M
15.11%
Vitamins, minerals and supplements
416.00M
14.58%
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dodge & Cox
3.77%
Fidelity Management & Research Company LLC
2.16%
ClearBridge Investments, LLC
0.73%
Harding Loevner LP
0.51%
UBS Financial Services, Inc.
0.32%
Other
92.51%
Investidores
Investidores
Proporção
Dodge & Cox
3.77%
Fidelity Management & Research Company LLC
2.16%
ClearBridge Investments, LLC
0.73%
Harding Loevner LP
0.51%
UBS Financial Services, Inc.
0.32%
Other
92.51%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
5.93%
Investment Advisor
5.10%
Hedge Fund
0.89%
Research Firm
0.50%
Bank and Trust
0.15%
Family Office
0.07%
Family Office
0.06%
Family Office
0.06%
Individual Investor
0.02%
Other
87.23%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
1043
571.37M
12.71%
-195.52M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
2023Q3
933
688.70M
14.92%
-37.88M
2023Q2
891
677.74M
14.68%
-44.11M
2023Q1
842
667.68M
14.46%
-14.30M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dodge & Cox
169.15M
3.77%
-9.59M
-5.37%
Mar 31, 2025
Fidelity Management & Research Company LLC
97.16M
2.16%
+2.47M
+2.61%
Mar 31, 2025
ClearBridge Investments, LLC
32.59M
0.73%
-208.31K
-0.64%
Mar 31, 2025
Harding Loevner LP
23.07M
0.51%
-1.05M
-4.37%
Mar 31, 2025
UBS Financial Services, Inc.
14.33M
0.32%
+7.63M
+113.98%
Mar 31, 2025
Fidelity Institutional Asset Management
14.29M
0.32%
+153.75K
+1.09%
Mar 31, 2025
Wellington Management Company, LLP
18.70M
0.42%
+3.37M
+22.00%
Mar 31, 2025
Sculptor Capital Management, Inc
10.85M
0.24%
+1.96M
+22.09%
Mar 31, 2025
Aristotle Capital Management, LLC
8.44M
0.19%
-314.11K
-3.59%
Mar 31, 2025
Douglas C. Lane & Associates
8.18M
0.18%
-431.27K
-5.01%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
VanEck Pharmaceutical ETF
5.25%
Franklin ClearBridge Enhanced Income ETF
2.13%
Fidelity Blue Chip Value ETF
0.92%
One Global ETF
0.91%
ActivePassive International Equity ETF
0.46%
SP Funds S&P World (ex-US) ETF
0.36%
Avantis International Equity ETF
0.12%
Avantis Responsible International Equity ETF
0.11%
Avantis International Large Cap Value ETF
0%
Knowledge Leaders Developed World ETF
0%
Ver Mais
VanEck Pharmaceutical ETF
Proporção5.25%
Franklin ClearBridge Enhanced Income ETF
Proporção2.13%
Fidelity Blue Chip Value ETF
Proporção0.92%
One Global ETF
Proporção0.91%
ActivePassive International Equity ETF
Proporção0.46%
SP Funds S&P World (ex-US) ETF
Proporção0.36%
Avantis International Equity ETF
Proporção0.12%
Avantis Responsible International Equity ETF
Proporção0.11%
Avantis International Large Cap Value ETF
Proporção0%
Knowledge Leaders Developed World ETF
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI